Yiviva Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC) (NCT04000737) | Yiviva Inc. | 2020-01-10 |
Track Yiviva Inc. automatically
Every clearance here is in the API, with alerts when new ones post.